BioPrinting Platform (Royce)
Details
- Value
- GBP 100,000
- Topic
- Laboratory, optical and precision equipments (excl. glasses)
- Published
- 30 January 2017
- Submission
- 28 February 2017
- Source
- ContractsFinder
Tender description
The University wishes to appoint a Contractor or Contractors to supply a BioPrinting Platform. The Henry Royce Institute is the UK's home of advanced materials research and innovation. The £235m Institute will allow the UK to grow its world-leading research and innovation base in advanced-materials science, which is fundamental to all industrial sectors and the national economy. It is a critical component of the Government's Northern Powerhouse initiative and an attempt to boost economic growth in the North of England and balance the UK economy. Royce operates on a hub-and-spoke model, with the hub based at The University of Manchester (UoM), and spokes at the founding partners; the universities of Sheffield, Leeds, Liverpool, Cambridge, Oxford and Imperial College London, as well as Culham Centre for Fusion Energy (CCFE) and the National Nuclear Laboratory (NNL). The equipment will be part of the Biomedical Systems and Devices theme within the Henry Royce Institute. The Biomedical Systems and Devices intends to accelerate the discovery, manufacture and translation of biomaterials through a platform of state-of-the-art equipment, enhancing the UK position as an international leader in the fields of biomaterials and biomedical systems and devices. This HUB will enable fabrication and evaluation equipment suites to allow the currently missing feedback loop for efficiency and optimisation to translate biomaterials/biomedical devices. The two identified grand challenges of advanced biomaterials research are restoring biological function within minimal invasiveness (e.g. regenerative medicine, novel prosthetics and implants) and developing new therapies that reduce patient risk, improve efficacy, and lower cost (e.g. nanomedicine theranostics and personalised medicine). The Biomedical Systems and Devices will enable the discovery of novel biomaterial and biomedical devices whilst accelerating the translation of such materials via scale up production facilities and efficient and appropriate evaluation and characterization suites.
Timeline
- Completed: Tender published30 January 2017Current notice
- Completed: Submission date28 February 2017
About the buyer
The University of Manchester is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 38000000 · Laboratory, optical and precision equipments (excl. glasses)
- 38800000 · Industrial process control equipment and remote-control equipment
- 38820000 · Remote-control equipment
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@the-university-of-manchester.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@the-university-of-manchester.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@the-university-of-manchester.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@the-university-of-manchester.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@the-university-of-manchester.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@the-university-of-manchester.gov |
13 similar open tenders
See more open tenders related to BioPrinting Platform (Royce).
- Open tender
Space Technology Solutions
- Open tender
MEDICAL TECHNOLOLGY (MEDTECH) INNOVATION DPS
Related topics
Topics related to BioPrinting Platform (Royce), ranked by notice volume.
- 863£4.2bn
- 1,745£636.1bn
Related buyers
Buyers similar to The University of Manchester.
- 337£19.0m
- 267£314.1m
- 130£195.8m
- 124£173.5m
- 114£48.2m
- 112£11.7m
- 101£60.1m
- 96£55.7m
- 90£25.5m
- 84£16.0m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
